Trulieve Cannabis (TRLV) Invested Capital (2020 - 2026)

Trulieve Cannabis has reported Invested Capital for 7 years, with the latest figure at $864.6 million in Q2 2026.

• On a quarterly basis, Invested Capital fell 34.83% year-over-year to $864.6 million in Q2 2026; TTM through Jun 2026 was $864.6 million, a 34.83% decrease from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 9.22% from the prior year.
• Invested Capital was $864.6 million for Q2 2026 at Trulieve Cannabis, down from $1.2 billion in the prior quarter.
• The five-year high for Invested Capital was $2.2 billion in Q2 2022, with the low at $864.6 million in Q2 2026.
• Average Invested Capital over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Invested Capital jumped 329.55% in 2022, then slumped 34.83% in 2026.
• Over 5 years, Invested Capital stood at $2.1 billion in 2022, then fell by 26.36% to $1.5 billion in 2023, then declined by 10.73% to $1.4 billion in 2024, then decreased by 9.22% to $1.2 billion in 2025, then sank by 30.45% to $864.6 million in 2026.
• The last three Invested Capital figures came in at $864.6 million (Q2 2026), $1.2 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.